Top

Published in:

01-07-2011 | Colorectal Cancer

The Impact of the Introduction of Total Mesorectal Excision on Local Recurrence Rate and Survival in Rectal Cancer: Long-Term Results

Authors: C. A. Maurer, MD, FRCS, FACS, P. Renzulli, MD, C. Kull, MD, S. A. Käser, MD, L. Mazzucchelli, MD, A. Ulrich, MD, M. W. Büchler, MD, FRCS

Published in: Annals of Surgical Oncology | Issue 7/2011

Abstract

Purpose

To investigate the influence of the introduction of total mesorectal excision (TME) on local recurrence rate and survival in patients with rectal cancer.

Methods

A total of 171 consecutive patients underwent anterior or abdominoperineal resection for primary rectal cancer. When the TME technique was introduced, the clinical setting, including the surgeons, remained the same. Group 1 (1993–95, n = 53) underwent conventional surgery and group 2 (1995–2001, n = 118) underwent TME. All patients were followed for 7 years or until death.

Results

Between the two groups, no statistically significant differences were present with regards to patient-, treatment-, or tumor-related characteristics apart from the time point of radiotherapy. The total local recurrence rates were 11 of 53 (20.8%) in group 1 and 7 of 118 (5.9%) in group 2, and the rates of isolated local recurrences were 6 of 53 (11.3%) in group 1 and 2 of 118 (1.7%) in group 2. Both differences were highly statistically significant. The disease-free survival in groups 1 and 2 was 60.4 and 65.3% at 5 years, and 58.5 and 65.3% at 7 years, respectively. Excluding patients with synchronous or metachronous distant metastasis from the analysis, both the disease-free survival and the cancer-specific survival were statistically significantly better in group 2 than in group 1. No statistically significant difference between the two groups was detected regarding the overall survival.

Conclusions

The introduction of TME led to an impressive reduction of the local recurrence rate. Survival is mainly determined by the occurrence of distant metastasis, but TME seems to improve survival in patients without systemic disease.

Heald RJ. Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus. Br J Surg. 1995;82:1297–9.PubMedCrossRef

Mella J, Biffin A, Radcliffe AG, Stamatakis JD, Steele RJ. Population-based audit of colorectal cancer management in two UK health regions. Colorectal Cancer Working Group, Royal College of Surgeons of England Clinical Epidemiology and Audit Unit. Br J Surg. 1997;84:1731–6.PubMedCrossRef

Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg. 1982;69:613–6.PubMedCrossRef

Maurer CA, Renzulli P, Meyer JD, Büchler MW. Rectal carcinoma. Optimizing therapy by partial or total mesorectum removal. Zentralbl Chir. 1999;124:428–35.PubMed

Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133:894–9.PubMedCrossRef

Enker WE, Merchant N, Cohen AM, et al. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg. 1999;230:544–52.PubMedCrossRef

Laurent C, Nobili S, Rullier A, Vendrely V, Saric J, Rullier E. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. J Am Coll Surg. 2006;203:684–91.PubMedCrossRef

Gunderson LL, Sargent DJ, Tepper JE, et al. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol. 2004;22:1785–96.PubMedCrossRef

Hermanek P, Wiebelt H, Staimmer D, Riedl S. Prognostic factors of rectum carcinoma—experience of the German Multicentre Study SGCRC. German Study Group colo-rectal carcinoma. Tumori. 1995;81:60–4.PubMed

10.

Kapiteijn E, Putter H, van de Velde CJ; Cooperative Investigators of the Dutch ColoRectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg. 2002;89:1142–9.PubMedCrossRef

11.

Bernardshaw SV, Øvrebø K, Eide GE, Skarstein A, Røkke O. Treatment of rectal cancer: reduction of local recurrence after the introduction of TME—experience from one university hospital. Dig Surg. 2006;23:51–9.PubMedCrossRef

12.

Tilney HS, Tekkis PP. Extending the horizons of restorative rectal surgery: intersphincteric resection for low rectal cancer. Colorectal Dis. 2008;10:3–15.PubMedCrossRef

13.

Wu AW, Gu J, Wang J, et al. Results after change of treatment policy for rectal cancer—report from a single hospital in China. Eur J Surg Oncol. 2007;33:718–23.PubMed

14.

Frileux P, Burdy G, Aegerter P, et al. Surgical treatment of rectal cancer: results of a strategy for selective preoperative radiotherapy. Gastroenterol Clin Biol. 2007;31:934–40.PubMedCrossRef

15.

Visser O, Bakx R, Zoetmulder FA, et al. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam. J Surg Oncol. 2007;95:447–54.PubMedCrossRef

16.

Chauvenet M, Lepage C, Jooste V, Cottet V, Faivre J, Bouvier AM. Prevalence of patients with colorectal cancer requiring follow-up or active treatment. Eur J Cancer. 2009;45:1460–5.PubMedCrossRef

17.

Sadahiro S, Suzuki T, Ishikawa K, et al. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology. 2003;50:1362–6.PubMed

18.

Liang YC, Qing SH, Ding WX, Chen PY, Huang YB, Yu HT. Total mesorectal excision versus conventional radical surgery for rectal cancer: a meta analysis (in Chinese). Zhonghua Wei Chang Wai Ke Za Zhi. 2007;10:43–8.PubMed

19.

den Dulk M, Krijnen P, Marijnen CA, et al. Improved overall survival for patients with rectal cancer since. 1990: The effects of TME surgery and pre-operative radiotherapy. Eur J Cancer. 2008;44:1710–6.CrossRef

20.

Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B; Norwegian Rectal Cancer Group. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg. 2007;94:113–8.PubMedCrossRef

21.

Peeters KC, Marijnen CA, Nagtegaal ID; Dutch Colorectal Cancer Group, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246:693–701.PubMedCrossRef

22.

Påhlman L. Population based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer. Tech Coloproctol. 2003;7:120–1.PubMed

23.

Dahlberg M, Påhlman L, Bergström R, Glimelius B. Improved survival in patients with rectal cancer: a population-based register study. Br J Surg. 1998;85:515–20.PubMedCrossRef

24.

Heald RJ. The “holy plane” of rectal surgery. J R Soc Med. 1988;81:503–8.PubMed

25.

Constantinides VA, Cheetham D, Nicholls RJ, Tekkis PP. Is rectal washout effective for preventing localized recurrence after anterior resection for rectal cancer? Dis Colon Rectum. 2008;51:1339–44.PubMedCrossRef

26.

Maurer CA, Z’Graggen K, Renzulli P, Schilling MK, Netzer P, Büchler MW. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery. Br J Surg. 2001;88:1501–5.PubMedCrossRef

27.

Maurer CA, Z’graggen K, Zimmermann W, Häni HJ, Mettler D, Büchler MW. Experimental study of neorectal physiology after formation of a transverse coloplasty pouch. Br J Surg. 1999;86:1451–8.PubMedCrossRef

28.

Z’graggen K, Maurer CA, Birrer S, Giachino D, Kern B, Büchler MW. A new surgical concept for rectal replacement after low anterior resection: the transverse coloplasty pouch. Ann Surg. 2001;234:780–5.PubMedCrossRef

29.

Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996–9.PubMedCrossRef

30.

Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303–12.PubMedCrossRef

31.

Swiss Society of Gastroenterology. Revised consensus recommendations for surveillance of colorectal cancer surgically treated in curative intent. http://www.sggssg.ch/Dokumente/Merkblaetter/NaSoCRCd.pdf (2007).

32.

Bakx R, Visser O, Josso J, Meijer S, Slors JF, van Lanschot JJ. Management of recurrent rectal cancer: a population based study in greater Amsterdam. World J Gastroenterol. 2008;14:6018–23.PubMedCrossRef

33.

Sauer R, Becker H, Hohenberger W; German Rectal Cancer Study Group, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–40.PubMedCrossRef

34.

Frykholm GJ, Glimelius B, Påhlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum. 1993;36:564–72.PubMedCrossRef

Title: The Impact of the Introduction of Total Mesorectal Excision on Local Recurrence Rate and Survival in Rectal Cancer: Long-Term Results
Authors: C. A. Maurer, MD, FRCS, FACS
P. Renzulli, MD
C. Kull, MD
S. A. Käser, MD
L. Mazzucchelli, MD
A. Ulrich, MD
M. W. Büchler, MD, FRCS
Publication date: 01-07-2011
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 7/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-011-1571-0

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

The Impact of the Introduction of Total Mesorectal Excision on Local Recurrence Rate and Survival in Rectal Cancer: Long-Term Results

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 7/2011

Outcome of Laparoscopic Resection for Colorectal Cancer in Patients with High Operative Risk

Inhibition of p600 Expression Suppresses Both Invasiveness and Anoikis Resistance of Gastric Cancer

Quality Improvement of Pancreatic Surgery by Centralization in the Western Part of the Netherlands

Interleukin-2 −330T>G Genetic Polymorphism Associates with Prognosis Following Surgery for Thoracic Esophageal Squamous Cell Cancer

Risk Factors, Prognosis, and Management of Early and Late Intrahepatic Recurrence After Resection of Primary Clear Cell Carcinoma of the Liver

Surgical Treatment of Renal Cell Cancer Liver Metastases: A Population-Based Study